IPO
GSK's $10.6 Billion Bet on Nuvalent: What It Means for the Biotech Sector
GSK's acquisition of Nuvalent for $10.6 billion signifies a strategic move in the precision oncology market, impacting its drug pipeline and competitive landscape.
June 9, 2026
Technology
Consolidated Lithium Metals Expands Footprint with Augustus Lithium Project
Consolidated Lithium Metals is set to acquire the Augustus Lithium Project, boosting its presence in the booming EV batt…
Jun 9
Economy
Small Business Sentiment Dips: NFIB's May Optimism Index Analysis
The NFIB's May Optimism Index reveals a decline in small business sentiment, highlighting rising uncertainty in the econ…
Jun 9
Analysis
APi Group Expands Its Reach: Insights from the Onyx-Fire Acquisition
APi Group's acquisition of Onyx-Fire marks a strategic expansion in the fire protection industry, with promising implica…
Jun 9
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Earnings
Wesco's $136M Newark Engineering Acquisition: A Play for Asian Market Footprint
Jun 9, 2026
Analysis
G2 Goldfields Gains Proxy Support for G Mining Deal: What Investors Should Know
Jun 4, 2026
